menu
    • menu

    Company profile for Devonian Health Group

    NEW Drugs in Dev: 2
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Devonian is a Canadian, publicly-traded (TSXv:GSD), late stage botanical pharmaceutical corporation with novel therapeutic approaches targeting worldwide unmet medical needs. Devonian’s core strategy is to develop prescription botanical drugs which could be from plant materials, algae, macroscopic fungi, and combinations thereof. This strategy is supported by FDA set of regulatory guidelines, favouring a more efficient drug ...
    Devonian is a Canadian, publicly-traded (TSXv:GSD), late stage botanical pharmaceutical corporation with novel therapeutic approaches targeting worldwide unmet medical needs. Devonian’s core strategy is to develop prescription botanical drugs which could be from plant materials, algae, macroscopic fungi, and combinations thereof. This strategy is supported by FDA set of regulatory guidelines, favouring a more efficient drug development pathway for prescription botanical drug products.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Devonian Health GroupCanada Flag
    Country
    Country
    Canada
    Address
    Address
    115 Place Frontenac, Pointe-Claire, Qc H9R 4Z7
    Telephone
    Telephone
    (450) 937-6696
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://groupedevonian.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Devonian Advances Thykamine Patent with Unique Fingerprint
    Devonian Advances Thykamine Patent with Unique Fingerprint

    17 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/devonian-advances-thykamine-patent-strategy-with-proprietary-fingerprint-and-robust-manufacturing-controls-302688840.html

    PR NEWSWIRE
    17 Feb 2026
    Share Share
    Devonian Reports Additional Molecular Data From MASH Liver Study
    Devonian Reports Additional Molecular Data From MASH Liver Study

    12 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/devonian-reports-additional-molecular-data-from-mash-liver-study-302685602.html

    PR NEWSWIRE
    12 Feb 2026
    Share Share
    Devonian Appoints Dennis Turpin as Chief Financial Officer
    Devonian Appoints Dennis Turpin as Chief Financial Officer

    02 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/devonian-appoints-dennis-turpin-as-chief-financial-officer-and-provides-updates-on-stock-options-grant-302675660.html

    PR NEWSWIRE
    02 Feb 2026
    Share Share
    Devonian Announces Share Consolidation for U.S. Listing
    Devonian Announces Share Consolidation for U.S. Listing

    20 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/devonian-announces-share-consolidation-in-further-preparation-for-potential-us-listing-302665122.html

    PR NEWSWIRE
    20 Jan 2026
    Share Share
    Devonian Health Group Announces Grant Of Stock Options
    Devonian Health Group Announces Grant Of Stock Options

    19 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/devonian-health-group-announces-grant-of-stock-options-302645904.html

    PR NEWSWIRE
    19 Dec 2025
    Share Share
    Devonian Health Announces Thykamine Anti-Inflammatory Study
    Devonian Health Announces Thykamine Anti-Inflammatory Study

    04 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/devonian-health-group-announces-publication-of-landmark-study-highlighting-thykamine-as-a-promising-new-anti-inflammatory-agent-302632712.html

    PR NEWSWIRE
    04 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search